Linking agonist binding to histamine H1 receptor activation

Nature Chemical Biology

Volumn 1, Issue 2, 2005, Pages 98-103

  Jongejan, Aldo ^a   Bruysters, Martijn ^a   Ballesteros, Juan A ^b   Haaksma, Eric ^c   Bakker, Remko A ^a   Pardo, Leonardo ^d   Leurs, Rob ^a  

^a VU UNIVERSITY AMSTERDAM   (Netherlands)

^b Novasite Pharmaceuticals Inc   (United States)

^c BOEHRINGER INGELHEIM RCV GMBH AND CO KG   (Austria)

^d UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

HISTAMINE AGONIST; HISTAMINE H1 RECEPTOR; SERINE;

ANIMAL; ARTICLE; CELL STRAIN COS1; CERCOPITHECUS; CHEMICAL STRUCTURE; CHEMISTRY; GENETICS; HUMAN; METABOLISM; MUTATION; PROTEIN TERTIARY STRUCTURE;

ANIMALS; CERCOPITHECUS AETHIOPS; COS CELLS; HISTAMINE AGONISTS; HUMANS; MODELS, MOLECULAR; MUTATION; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, HISTAMINE H1; SERINE;

EID: 26444467486     PISSN: 15524450     EISSN: 15524469     Source Type: Journal    
DOI: 10.1038/nchembio714     Document Type: Article

References (47)

1. Unger, V.M., Hargrave, P.A., Baldwin, J.M. & Schertler, G.F. Arrangement of rhodopsin transmembrane α-helices. Nature 38, 203-206 (1997).
2. Palczewski, K. et al. Crystal structure of rhodopsin: A G protein-coupled receptor. Science 289, 739-745 (2000).
3. Deupi, X. et al. Conformational plasticity of GPCR binding sites; structural basis for evolutionary diversity in ligand recognition. in The G Protein-Coupled Receptors Handbook (ed. Devi, L.A.) (Humana Press, Totowa, 2005).
4. Mirzadegan, T., Benko, G., Filipek, S. & Palczewski, K. Sequence analyses of G-protein-coupled receptors: similarities to rhodopsin. Biochemistry 42, 2759-2767 (2003).
5. Shi, L. & Javitch, J.A. The binding site of aminergic G protein-coupled receptors: the transmembrane segments and second extracellular loop. Annu. Rev. Pharmacol. Toxicol. 42, 437-467 (2002).
6. Ballesteros, J.A. & Weinstein, H. Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein coupled receptors. Methods Neurosci. 25, 366-428 (1995).
7. 194. Biochem. Biophys. Res. Commun. 203, 1096-1101 (1994).
8. 1 receptor. Eur. J. Pharmacol. 345, 111-117 (1998).
9. 1-receptorbindingpocketof histaprodifens. Eur. J. Pharmacol. 487, 55-63 (2004).
10. 1 histamine receptor. in Animal Cell Technology: Basic & Applied Aspects, Vol. 9 (eds. Nagai, K. & Wachi, M.) 65-69 (Kluwer Academic Publishers, Dordrecht, 1998).
11. 1 receptor. J. Biol. Chem. 274, 29994-30000 (1999).
12. 194. Mol. Pharmacol. 61, 391-399 (2002).
13. 1 agonists. Biochem. Biophys. Res. Commun. 214, 110-117 (1995).
14. 1-receptor agonsits. Biochem. Biophys. Res. Commun. 201, 295-301 (1994).
15. 1 histamine receptor stably expressed in CHO cells. J. Recept. Signal Transduct. Res. 15, 91-102 (1995).
16. Visiers, I., Ballesteros, J.A. & Weinstein, H. Three-dimensional representations of G protein-coupled receptor structures and mechanisms. Methods Enzymol. 343, 329-371 (2002).
17. 2 adrenergic receptor activation. Modulation of the proline kink in transmembrane 6 by a rotamer toggle switch. J. Biol. Chem. 277, 40989-40996 (2002).
18. Ruprecht, J.J., Mielke, T., Vogel, R., Villa, C. & Schertler, G.F.X. Electron crystallography reveals the structure of metarhodopsin I. EMBO J. 23, 3609-3620 (2004).
19. Ballesteros, J.A. et al. Activation of the β2-adrenergic receptor involves disruption of an ionic lock between the cytoplasmic ends of transmembrane segments 3 and 6. J. Biol. Chem. 276, 29171-29177 (2001).
20. 2A receptor by disruption of the ionic lock of the arginine cage. Int. J. Quantum Chem. 88, 65-75 (2002).
21. 1B-adrenergic receptor: potential role of protonation and hydrophobicity of a highly conserved aspartate. Proc. Natl. Acad. Sci. USA 94, 808-813 (1997).
22. Oliveira, L., Paiva, A.C.M., Sander, C. & Vriend, G. A model for G protein interaction in G protein coupled receptors. Trends Pharmacol. Sci. 15, 170-172 (1994).
23. 2 adrenoceptor function. Evidence for protonation-dependentactivation. J. Biol. Chem. 275, 3121-3127 (2000).
24. Farrens, D.L., Altenbach, C., Yang, K., Hubbell, W.L. & Khorana, H.G. Requirement of rigid-body motion of transmembrane helices for light activation of rhodopsin. Science 274, 768-770 (1996).
25. Gether, U., Asmar, F., Meinild, A.K. & Rasmussen, S.G.F. Structural basisforactivation of G-protein-coupled receptors. Pharmacol. Toxicol. 91, 304-312 (2002).
26. Meng, E.C. & Bourne, H.R. Receptoractivation: whatdoestherhodopsin structuretell us? Trends Pharmacol. Sci. 22, 587-593 (2001).
27. Govaerts, C. et al. A conserved Asn in transmembrane helix 7 is an on/off switch in the activation of the thyrotropin receptor. J. Biol. Chem. 276, 22991-22999 (2001).
28. Urizar, E. et al. An activation switch in the rhodopsin family of G protein coupled receptors: the thyrotropin receptor. J. Biol. Chem. 280, 17135-17141 (2005).
29. Claeysen, S. et al. A conserved Asn in TM7 of the thyrotropin receptor is a common requirementfor activation byboth mutations and itsnatural agonist. FEBSLett. 517, 195-200 (2002).
30. Hubbell, W.L., Altenbach, C., Hubbell, C.M. & Khorana, H.G. Rhodopsin structure, dynamics, and activation: a perspective from crystallography, site-directed spin label-ing, sulfhydryl reactivity, and disulfide cross-linking. Adv. Protein Chem. 63, 243-290 (2003).
31. 2A receptor. Ser3.36(159) provides a second interaction site for the protonated amine of serotonin but not of lysergic acid diethylamide or bufotenin. J. Biol. Chem. 271, 14672-14675 (1996).
32. Akabas, M.H., Stauffer, D.A., Xu, M. & Karlin, A. Acetylcholine receptor channel structure probed in cysteine-substitution mutants. Science 258, 307-310 (1992).
33. 1-receptor activation of nuclear factor-κB: roles for Gβγ-and Gαq/11-subunits in constitutive and agonist-mediated signaling. Mol. Pharmacol. 60, 1133-1142 (2001).
34. Ballesteros, J.A., Deupi, X., Olivella, M., Haaksma, E.E.J. & Pardo, L. Serine and threonine residues bend α-helices in the χ1 = g- conformation. Biophys. J. 79, 2754-2760 (2000).
35. 1 receptor activation. J. Biol. Chem. 279, 48024-48037 (2004).
36. Li, J., Edwards, P.C., Burghammer, M., Villa, C. & Schertler, G.F.X. Structure of bovine rhodopsin in a trigonal crystal form. J. Mol. Biol. 343, 1409-1438 (2004).
37. Goldman, L.A., Cutrone, E.C., Kotenko, S.V., Krause, C.D. & Langer, J.A. Modifications of vectors pEF-BOS, pcDNA1 and pcDNA3 result in improved convenience and expression. Biotechniques 21, 1013-1015 (1996).
38. 1 receptor gene. Biochem. Biophys. Res. Commun. 201, 894-901 (1994).
39. Bradford, M.M. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254 (1976).
40. Okada, T. et al. Functional role of internal water molecules in rhodopsin revealed by X-ray crystallography. Proc. Natl. Acad. Sci. USA 99, 5982-5987 (2002).
41. 1a receptor ligands to explore the three-dimensional structure of the receptor. Mol. Pharmacol. 62, 15-21 (2002).
42. 2 receptor lines the binding-site crevice. Proc. Natl. Acad. Sci. USA 101, 440-445 (2004).
43. Canutescu, A.A., Shelenkov, A.A. & Dunbrack, R.L., Jr. A graph-theory algorithm for rapid protein side-chain prediction. Protein Sci. 12, 2001-2014 (2003).
44. Case, D.A. et al. AMBER 8. (UniversityofCalifornia, San Francisco, 2004).
45. Wang, J., Cieplak, P. & Kollman, P.A. How well does a restrained electrostatic potential (RESP) model perform in calculating conformational energies of organic and biological molecules? J. Comput. Chem. 21, 1049-1074 (2000).
46. Frisch, M.J. et al. Gaussian 98, Revision A.11. (Gaussian Inc., Pittsburgh Pennsylva-nia, 2001).
47. Kraulis, P.J. MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures. J. Appl. Crystallogr. 24, 946-950 (1991).